- Home
- TECH vs MIST Comparison
TECH vs MIST Comparison
Compare TECH & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- MIST
- Stock Information
- Founded
- TECH 1976
- MIST 2003
- Country
- TECH United States
- MIST Canada
- Employees
- TECH N/A
- MIST N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- TECH Health Care
- MIST Health Care
- Exchange
- TECH Nasdaq
- MIST Nasdaq
- Market Cap
- TECH 8.0B
- MIST N/A
- IPO Year
- TECH 1989
- MIST N/A
- Fundamental
- Price
- TECH $50.24
- MIST $1.28
- Analyst Decision
- TECH Buy
- MIST Strong Buy
- Analyst Count
- TECH 8
- MIST 2
- Target Price
- TECH $81.14
- MIST $9.50
- AVG Volume (30 Days)
- TECH 2.3M
- MIST 3.7M
- Earning Date
- TECH 05-07-2025
- MIST 05-12-2025
- Dividend Yield
- TECH 0.64%
- MIST N/A
- EPS Growth
- TECH N/A
- MIST N/A
- EPS
- TECH 0.98
- MIST N/A
- Revenue
- TECH $1,196,016,000.00
- MIST N/A
- Revenue This Year
- TECH $8.19
- MIST N/A
- Revenue Next Year
- TECH $8.85
- MIST N/A
- P/E Ratio
- TECH $51.28
- MIST N/A
- Revenue Growth
- TECH 4.46
- MIST N/A
- 52 Week Low
- TECH $46.44
- MIST $0.63
- 52 Week High
- TECH $85.57
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- TECH 40.99
- MIST 54.17
- Support Level
- TECH $46.01
- MIST $1.09
- Resistance Level
- TECH $53.54
- MIST $0.88
- Average True Range (ATR)
- TECH 3.20
- MIST 0.10
- MACD
- TECH 0.29
- MIST 0.09
- Stochastic Oscillator
- TECH 50.84
- MIST 94.24
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.